In HCC, all-trans retinoic acid (ATRA) enhances TFPI2 via retinoic acid receptor alpha (RARα), modulated by MAF bZIP transcription factor B (MAFB, activator) and MAFF (repressor), influencing tumor invasion [111,112]. Here, TFPI2 is linked to hepatocellular carcinoma.